SPY322.64-7.66 -2.32%
DIA267.58-5.23 -1.92%
IXIC10,632.99-330.65 -3.02%

Guggenheim Yesterday Downgraded Spectrum Pharmaceuticals to Neutral

Guggenheim analyst Michael Schmidt yesterday downgraded Spectrum Pharmaceuticals (NASDAQ:SPPI) from Buy to Neutral.

Benzinga · 12/27/2019 13:11

Guggenheim analyst Michael Schmidt yesterday downgraded Spectrum Pharmaceuticals (NASDAQ:SPPI) from Buy to Neutral.